Apr 11, 2026

Featuring perspectives from Dr Paul G Richardson, including the following topics:

• EXCALIBER-RRMM: A Phase III trial of iberdomide, daratumumab and dexamethasone for relapsed/refractory multiple myeloma (0:00)
  • Lonial S et al. EXCALIBER-RRMM: A phase III trial of iberdomide, daratumumab, and dexamethasone...

Apr 1, 2026

Featuring an interview with Dr Hanny Al-Samkari, including the following topics:

• Case: A man in his early 40s with chronic immune thrombocytopenia (ITP) receives romiplostim with rituximab — Bhavana (Tina) Bhatnagar, DO (0:00)
• Case: A woman in her early 80s with metastatic adenocarcinoma of the lung responds to...

Mar 23, 2026

Featuring perspectives from Dr Paul G Richardson, including the following topics:

• Mechanism of action and pharmacology of cereblon E3 ligase modulators (0:00)
• Available efficacy data (4:54)
• Extramedullary disease (10:51)
• Side effects and toxicity (16:58)

CME information and select...

Mar 21, 2026

Featuring an interview with Dr Hanny Al-Samkari, including the following topics:

• Case: A woman in her early 70s incidentally diagnosed with immune thrombocytopenia (ITP) experiences a suboptimal response to prednisone and IVIG — Bhavana (Tina) Bhatnagar, DO (0:00)
• Case: A man in his early 50s with a long history of...

Mar 13, 2026

Featuring an interview with Dr Bijal Shah, including the following topics:

• Advent and importance of blinatumomab in the therapeutic landscape of acute lymphoblastic leukemia (ALL) (0:00)
• Similarities and differences between bispecific T-cell engagers (BiTEs) and bispecific antibodies (5:51)
• Rationale underlying the...